Friday, 25 May 2018

You are here

RheumNow Week in Review - 29 July 2016

Dr Jack Cush reviews this week's highlights from RheumNow.com.

  1. RA: risk of serious infection rises with Interstitial lung dz; 2 fold higher in 1st yr; higher with BOOP & steroids >10mg/day. https://t.co/axzUZhrtHD
  2. FDA warns against using fluoroquinolones (to Rx UTI, bronchitis etc) if other safer Rx options exist. https://t.co/UA0uNmcW3O
  3. Quercetin shown to signif. reduce Uric acid, it inhibits xanthine oxidoreductase in vitro. Not studied in gout. https://t.co/0Fq95UK3PS
  4. CHMP has recommended abatacept for 1st line use (before MTX) in moderate to severe RA. EMA to consider approval https://t.co/kXyD1cXKbO
  5. Anakinra not effective if added to MTX in early RA: CARDERA2 study of 154pts Rx x2yrs. No xray benefit, less DAS/HAQ https://t.co/owvwPhhtss
  6. UK audit of 5000 RA shows only 20% referred from GP to Rheum in 3days (NICE target). Wait time to see Rheum 23-34d https://t.co/5jwIa90EL6
  7. FDA Panel Recommends Brodalumab Approval in Psoriasis
  8. Pravastatin Improves Obstetric Outcomes in Anti-Phospholipid Syndrome Patients. 
  9. Long-Term Safety of Adalimumab Reviewed
  10. MACRA for the Overwhelmed Rheumatologist
  11. The Purse Exam: a Forgotten Part of the Physical. 
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past week's news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on RheumNow.com.

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.